| Bioactivity | Gadoteridol is a gadolinium-based magnetic resonance imaging (MRI) contrast agent, used in the imaging of the central nervous system[1]. | ||||||||||||
| In Vivo | Gadoteridol (1 mM; intracerebral injection; once) enhances distribution of rAAV1 in the rat hippocampus[1]. Animal Model: | ||||||||||||
| Name | Gadoteridol | ||||||||||||
| CAS | 120066-54-8 | ||||||||||||
| Formula | C17H28GdN4O7 | ||||||||||||
| Molar Mass | 557.68 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Hullinger R, et al. The MRI contrast agent gadoteridol enhances distribution of rAAV1 in the rat hippocampus. Gene Ther. 2013 Dec;20(12):1172-7. |
Gadoteridol
CAS: 120066-54-8 F: C17H28GdN4O7 W: 557.68
Gadoteridol is a gadolinium-based magnetic resonance imaging (MRI) contrast agent, used in the imaging of the central ne
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.